|
STX7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
1.07192033027559E-12 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
2.616600E-01 |
| Stage1-vs-Stage3 |
1.446210E-01 |
| Stage1-vs-Stage4 |
2.196000E-02 |
| Stage2-vs-Stage3 |
9.747800E-01 |
| Stage2-vs-Stage4 |
3.657600E-01 |
| Stage3-vs-Stage4 |
2.957600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.8285000008843E-08 |
| Normal-vs-Asian |
1.99840144432528E-11 |
| Caucasian-vs-AfricanAmerican |
5.551600E-01 |
| Caucasian-vs-Asian |
5.447000E-01 |
| AfricanAmerican-vs-Asian |
8.982000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
6.003400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62725388719309E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.52968999999059E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.249190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.086200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.257000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.674200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.040200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.448800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.142400E-01 |
| Classical-VS-Follicular |
5.888100E-02 |
| Classical-VS-Other |
8.184800E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
7.079600E-01 |
| Tall-VS-Other |
5.083400E-01 |
| Tall-VS-Normal |
5.1760995489758E-10 |
| Follicular-VS-Other |
4.502800E-01 |
| Follicular-VS-Normal |
1.63424829224823E-12 |
| Other-VS-Normal |
2.137600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
7.01327884655711E-13 |
| N0-vs-N1 |
7.450000E-01 |
|
|
